Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.31 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.30 |
| ▸ | TGM2 | P21980 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL160241 | 0.77 | ALDH1A1 (0.41) | ALDH1A1TSHRESR1ESR2TGM2 | |
| SCHEMBL9418213 | 0.69 | TSHR (0.35) | ALDH1A1TSHRTGM2 | |
| SCHEMBL9418211 | 0.69 | TSHR (0.35) | ALDH1A1TSHRTGM2 | |
| SCHEMBL11024215 | 0.69 | ALDH1A1 (0.36) | ALDH1A1TSHRMEN1KMT2ATGM2 | |
| SCHEMBL8002913 | 0.67 | ALDH1A1 (0.32) | ALDH1A1TSHRESR1ESR2 | |
| SCHEMBL28638586 | 0.67 | MAPT (0.35) | TSHRESR1ESR2 | |
| SCHEMBL439491 | 0.65 | ESR1 (0.36) | ALDH1A1TSHRMEN1KMT2AESR1 | |
| SCHEMBL49539 | 0.65 | TSHR (0.39) | ALDH1A1TSHRMEN1KMT2AESR1 | |
| SCHEMBL226240 | 0.65 | ALDH1A1 (0.41) | ALDH1A1TSHRMEN1KMT2AESR1 | |
| SCHEMBL1674781 | 0.65 | ALDH1A1 (0.41) | ALDH1A1TSHRESR1ESR2TGM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3983461-A1 | SILYL-CONTAINING ACRYLATES AND DEGRADABLE RADICAL-CURED NETWORKS THEREOF | The Government of the United States of America, as represented by the Secretary of the Navy (US) | 2022-04-20 | — | — | EP | disclosed |
| WO-2020252489-A1 | SILYL-CONTAINING ACRYLATES AND DEGRADABLE RADICAL-CURED NETWORKS THEREOF | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2020-12-17 | — | — | WO | disclosed |
| US-20200392273-A1 | SILYL-CONTAINING ACRYLATES AND DEGRADABLE RADICAL-CURED NETWORKS THEREOF | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2020-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200392273-A1 | SILYL-CONTAINING ACRYLATES AND DEGRADABLE RADICAL-CURED NETWORKS THEREOF | LSM14A, MGMT, AS3MT | ALDH1A1 263/4885TSHR 3117/4885MEN1 1270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.